4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040564
SVP, CFO sold 8,186 shares at an average $1.65 ($13,527)
From the SEC's structured data for this filing
Trades in this filing
Hyllengren Eric J · SVP, CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-16 | Sale : show line 1 in the form | −6,408 | $1.65 | $10,586 | 219,734 | D |
| 2023-08-16 | Sale : show line 2 in the form | −1,778 | $1.65 | $2,941 | 217,956 | D |
| Open-market sales · 8,186 sh · avg $1.65 · $13,527 | ||||||
Loading xslF345X05/form4.xml…